News | February 02, 2009

MRI Used to Demystify Cardiovascular Consequences of Obstructive Sleep Apnea


February 2, 2009 - Researchers at the Ohio State University Medical Center are using cardiac magnetic resonance imaging to assess the effects of a common treatment for sleep apnea on heart structure and function in otherwise healthy individuals.
The study authored by Ulysses Magalang, M.D. and Subha Raman, M.D. appears in the Journal of Clinical Sleep Medicine.
“Little data exists on continuous positive airway pressure’s therapeutic effects on the heart’s right side, so we are leveraging the advantages of imaging to see if the treatment helps these patients,” said Dr. Magalang, medical director of Ohio State’s Sleep Disorders Center.
Researchers found that continuous positive airway pressure therapy (CPAP) improves heart structure with improvements in the volume of the right ventricle. CPAP is administered by a device that delivers continuous positive airway pressure during sleep. The device encompasses a mask worn over the nose, tubing and a fan that delivers enough air pressure to keep the throat open, preventing obstruction of the airway, and reversing the negative consequences of sleep apnea on the heart.
“By getting clear pictures of the heart in these patients, we were able to better understand the cardiovascular consequences of obstructive sleep apnea. These results can be used to guide treatments to reduce death and disability due to heart disease,” said Dr. Raman, medical director of the cardiac magnetic resonance and computerized tomography program at Ohio State’s Richard M. Ross Heart Hospital.
Drs. Magalang and Raman recently collaborated on a study published in the journal Experimental and Clinical Endocrinology & Diabetes showing a possible link between sleep apnea and heart disease, which is the leading cause of death responsible for 29 percent of people worldwide. The researchers identified a substance that may prevent atherosclerosis.
For more information: www.osumc.edu


Related Content

News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Home February 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy ...

Home November 17, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

Home June 28, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA ...

Home June 20, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...

Home June 07, 2023
Home
Feature | Magnetic Resonance Imaging (MRI) | By Johnson Polakkal Joseph

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in ...

Home May 01, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...

Home April 18, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 4, 2023 — Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of ...

Home April 04, 2023
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in ...

Home November 17, 2022
Home
News | Magnetic Resonance Imaging (MRI)

November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left ...

Home November 09, 2022
Home
Subscribe Now